Clinical Trial Update: Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer

View source ↗

Summary

A clinical trial evaluating eribulin (Halaven) for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Eisai Farmacêutica S.A. | Conditions: Metastatic Breast Cancer | Status: COMPLETED